No.208 Zhangbai Road
Dongxihu District
Wuhan 430042
China
86 27 8860 5516
https://www.whhsyy.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 1,068
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Weiyuan Zhang | Chairman & GM | N/D | N/D | 1969 |
Mr. Jie Liu | Vice Chairman & Chief Scientist | N/D | N/D | 1964 |
Mr. Kaijie Yang | Deputy GM & CFO | N/D | N/D | 1970 |
Mr. Zexiang Liu | Director & Assistant to the GM | N/D | N/D | 1976 |
Mr. Jie Han | Deputy General Manager | N/D | N/D | 1985 |
Ms. Hongxia Li | Director of Warehousing & Logistics Data and Supervisor | N/D | N/D | 1976 |
Ms. Jian Zhou | Chairman of the Supervisory Board & Assistant to the GM | N/D | N/D | 1974 |
Mr. Wenge Ding | Product & Technical Service Director and Supervisor | N/D | N/D | 1969 |
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin tartrate powders and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.
La calificación ISS Governance QuickScore de Hvsen Biotechnology Co., Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.